EDF1 Human

Endothelial Differentiation-Related Factor 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions

EDF1 exhibits dual roles in cytoplasmic and nuclear processes:

Ribosome Quality Control (RQC)

EDF1 is recruited to collided ribosomes during translational stalls, where it:

  • Facilitates ZNF598-mediated ubiquitylation of ribosomal proteins eS10 and uS10 to tag faulty mRNAs .

  • Recruits GIGYF2- EIF4E2 complexes to repress further translation initiation, forming a negative feedback loop .

  • Requires RACK1 for polysome association under stress (e.g., UV irradiation, emetine treatment) .

Transcriptional Regulation

  • PPARγ Activation: EDF1 translocates to the nucleus upon VEGF stimulation, enhancing PPARγ-driven transcription in endothelial cells .

  • Stress Response Genes: Coordinates transcriptional upregulation of JUN, ATF3, and EGR1 during ribosomal collisions .

Endothelial Differentiation

EDF1 modulates nitric oxide synthase activity via calmodulin sequestration, influencing vascular development .

Table 2: Mechanistic Insights from Recent Studies

Study FocusKey FindingsSource
Ribosome CollisionsEDF1 binds collided ribosomes near mRNA entry channels (Cryo-EM structure) and recruits RQC factors .
Transcriptional RoleEDF1 depletion reduces emetine-induced expression of JUN and ATF3 by >50% .
VEGF SignalingVEGF treatment increases nuclear EDF1 by 3-fold within 1 hour, enhancing PPARγ activity .
Evolutionary ConservationArchaeal EDF1 homologs lack the MBF1 domain but retain ribosome-binding HTH domains .

Protein Interactions and Pathways

EDF1 serves as a hub for diverse molecular complexes:

Table 3: EDF1 Interaction Network

Interacting PartnerRole
ZNF598Ubiquitin ligase in ribosome-associated quality control .
GIGYF2- EIF4E2Translation repressors recruited to stalled ribosomes .
PPARγNuclear receptor activated during endothelial differentiation .
TBP (TATA-Box Protein)Transcriptional coactivation via direct binding .

Research and Clinical Applications

  • Recombinant EDF1: Used in in vitro studies to probe ribosome collision responses and transcriptional mechanisms .

  • Therapeutic Target: Potential role in diseases linked to translational dysregulation (e.g., neurodegeneration) .

Future Directions

  • Elucidate EDF1’s role in cancer progression, given its control over stress-response transcription factors.

  • Develop small-molecule inhibitors targeting EDF1-RACK1 interactions to modulate RQC pathways.

Product Specs

Introduction
EDF1 is a protein that plays a crucial role in the differentiation of endothelial cells, which are the cells that line the inner surface of blood vessels. It acts as a bridge between regulatory proteins and the machinery responsible for gene transcription, thereby influencing the expression of genes involved in endothelial differentiation. EDF1 achieves this by binding to calmodulin, a calcium-binding protein, through its IQ domain. This interaction allows EDF1 to regulate nitric oxide synthase activity by sequestering calmodulin in the cytoplasm. EDF1 is found in various adult tissues, including the liver, heart, adipose tissue, intestine, and pancreas.
Description
This product consists of recombinant human EDF1 protein produced in E. coli bacteria. It is a single, non-glycosylated polypeptide chain comprising 156 amino acids (specifically, amino acids 1 to 148) and has a molecular weight of 17.4 kDa. An 8-amino acid His-Tag is fused to the C-terminus of the protein to facilitate purification using proprietary chromatographic techniques.
Physical Appearance
The product is a clear, colorless solution that has been sterilized by filtration.
Formulation
The product is provided as a solution with a concentration of 0.5 mg/ml. The solution is buffered with 20mM Tris at pH 8 and contains 1mM DTT, 0.1M NaCl, and 20% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product should be kept refrigerated at 4°C. For longer storage, it should be frozen at -20°C. To ensure optimal stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is recommended. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of the EDF1 protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
EDF-1, MBF1, Multiprotein-bridging factor 1.
Source
Escherichia Coli.
Amino Acid Sequence
MAESDWDTVT VLRKKGPTAA QAKSKQAILA AQRRGEDVET SKKWAAGQNK QHSITKNTAK LDRETEELHH DRVTLEVGKV IQQGRQSKGL TQKDLATKIN EKPQVIADYE SGRAIPNNQV LGKIERAIGL KLRGKDIGKP IEKGPRAKLE HHHHHH.

Q&A

What is the molecular structure and domain organization of human EDF1?

Human EDF1 is a 16.4 kDa protein comprising two main domains: an N-terminal multiprotein bridging factor 1 (MBF1) domain and a conserved C-terminal cro/C1-type helix-turn-helix (HTH) domain. Crystallographic and cryo-EM analyses have revealed its tertiary structure, with the HTH domain being particularly important for ribosomal interactions. The protein's architectural features are evolutionarily conserved, though archaeal orthologs display a zinc-ribbon domain rather than the N-terminal MBF1 domain seen in eukaryotes . When designing experiments to study EDF1, researchers should consider that residues Ser-24 to Arg-133 represent the region most amenable to structural analysis based on existing cryo-EM density maps .

How is EDF1 conserved across evolutionary lineages, and what does this suggest about its functional significance?

EDF1 demonstrates strong evolutionary conservation across eukaryotes and archaea but is notably absent in bacteria. This conservation pattern suggests its fundamental role in translational regulation evolved after the divergence of bacteria from the universal common ancestor. The archaeal homologs retain the C-terminal HTH domain while replacing the N-terminal MBF1 domain with a zinc-ribbon motif . Archaeal MBF1 shows weak association with 30S and 70S ribosomes, suggesting the ribosome-binding function predates the eukaryotic adaptation of EDF1 to collided ribosomes . When comparing homologs across species, researchers should pay particular attention to the conservation of interaction surfaces, especially those mediating contact with ribosomes and binding partners like translational repressors.

What experimental methods are most effective for detecting EDF1 association with ribosomes under normal and stress conditions?

Sucrose gradient fractionation combined with quantitative proteomics represents the gold standard for analyzing EDF1's dynamic association with ribosomes. Under normal growth conditions, EDF1 shows minimal association with polysomes, but upon induction of ribosomal collisions (using treatments like low-dose emetine at 1.8 μM for 15 minutes), it robustly associates with polysomal fractions . Western blotting of gradient fractions provides qualitative assessment, while TMT-based mass spectrometry offers quantitative measurement of EDF1 recruitment to different ribosomal subpopulations. For researchers designing such experiments, it's crucial to include appropriate controls that distinguish between collided and uncollided polysomes, such as comparing untreated cells to those with translation-perturbing agents .

What are the optimal approaches for studying EDF1's role in ribosome collision responses?

To comprehensively investigate EDF1's function in ribosomal collision responses, researchers should implement a multi-faceted experimental strategy:

  • Ribosome Profiling: Apply ribosome profiling with and without collision-inducing agents (e.g., low-dose emetine) in wild-type and EDF1-knockout cells to map genome-wide translation dynamics.

  • Affinity Purification-Mass Spectrometry: Use both conventional immunoprecipitation and proximity-based approaches (BioID) to identify EDF1 interaction partners under normal and collision-inducing conditions .

  • Cryo-EM Analysis: Purify EDF1-bound ribosomal complexes for structural characterization, focusing on the interface between collided ribosomes .

  • Reporter Assays: Employ dual-luciferase reporters containing sequences that induce ribosomal collisions (e.g., unspliced Xbp1 mRNA) to measure translation output in the presence or absence of EDF1 .

For optimal results, these approaches should be integrated to correlate structural insights with functional outcomes at both molecular and cellular levels.

How can researchers effectively generate and validate EDF1 knockout cell lines for functional studies?

Generating robust EDF1 knockout cell lines requires careful design and thorough validation:

Generation Strategy:

  • CRISPR-Cas9 targeting of early exons with multiple guide RNAs to ensure complete functional disruption

  • Selection of multiple independent clonal populations to control for clonal effects

Validation Approach:

  • Genomic Verification: PCR and sequencing of the targeted locus

  • Protein Expression: Western blot analysis using validated antibodies

  • Functional Assessment: Measurement of known EDF1-dependent processes, such as ribosomal collision responses

  • Rescue Experiments: Reintroduction of wild-type EDF1 to confirm phenotype specificity

Successful validation must include all these elements, as demonstrated in previous studies where multiple ΔEDF1 clones were characterized and showed consistent decreases in eS10 and uS10 ubiquitylation following UV treatment compared to wild-type cells .

What quantitative proteomics approaches provide the most comprehensive analysis of EDF1-dependent ribosome association dynamics?

For optimal quantitative analysis of EDF1-dependent ribosome association dynamics, researchers should implement a structured proteomics workflow:

  • Experimental Design: Compare wild-type and ΔEDF1 cell lines under both basal and collision-inducing conditions (e.g., low-dose emetine treatment) .

  • Fractionation Approach: Resolve lysates across 10-50% sucrose gradients and collect fractions corresponding to different ribosomal populations (light polysomes: fractions 6-8; heavy polysomes: fractions 9-11) .

  • Quantification Strategy: Apply TMTpro labeling for multiplexed analysis, enabling direct comparison across multiple conditions simultaneously.

  • Data Analysis Pipeline:

    • Normalize to total protein levels per fraction

    • Calculate enrichment ratios (treated/untreated) for each protein

    • Compare these ratios between wild-type and knockout conditions

    • Apply statistical filtering to identify proteins whose ribosome association is significantly altered in an EDF1-dependent manner

This approach has successfully identified factors like GIGYF2 and EIF4E2 whose recruitment to collided ribosomes depends on EDF1 .

How does EDF1 coordinate both transcriptional and translational responses to ribosomal collisions?

EDF1 functions as a multifunctional adaptor that bridges cytoplasmic translational stress to nuclear transcriptional responses through several mechanistic pathways:

  • Translational Regulation: Upon recruitment to collided ribosomes, EDF1 serves as a platform for assembling translational repressors GIGYF2 and EIF4E2, establishing a negative feedback loop that prevents additional ribosomes from initiating translation on defective mRNAs .

  • Transcriptional Activation: EDF1 functions as an evolutionarily conserved transcriptional coactivator that initiates transcriptional reprogramming in response to cellular stresses . It interacts with transcription factors like JUN, potentially coupling ribosomal collision events to immediate-early gene expression responses .

  • Nuclear-Cytoplasmic Shuttling: The dynamics of EDF1's subcellular localization likely play a critical role in its dual functionality, though the precise mechanisms governing its redistribution between ribosomes and chromatin require further investigation.

These integrated functions position EDF1 as a central coordinator in a cellular surveillance system that detects translational abnormalities and triggers appropriate adaptive responses at both translational and transcriptional levels.

What is the structural basis for EDF1's selective recognition of collided versus uncollided ribosomes?

The structural basis for EDF1's selective recognition of collided ribosomes involves several critical elements:

  • Binding Interface: Cryo-EM analyses reveal that EDF1 binds near the mRNA entry channel on the 40S subunit at a position proximal to the interface between collided ribosomes . This strategic positioning allows it to specifically recognize the unique conformational signatures created when ribosomes collide.

  • RACK1 Dependency: EDF1 recruitment to collided ribosomes requires RACK1, which is positioned at the collision interface and likely serves as either a direct binding partner or stabilizes the collision interface to create the EDF1 binding site .

  • Conformational Recognition: The structure suggests EDF1 recognizes a specific conformational state of the 40S subunit that occurs primarily in the context of ribosomal collisions, explaining why EDF1 shows minimal association with ribosomes under normal growth conditions.

  • Evolutionary Conservation: The binding site and recognition mechanism appear conserved, as both human EDF1 and its yeast homolog Mbf1 associate with the 40S subunit in similar positions .

Understanding this structural selectivity provides insight into how cells discriminate between normal translation and pathological states requiring quality control interventions.

How does EDF1 interact with the ubiquitination machinery during ribosome-mediated quality control?

EDF1 plays a facilitating but non-essential role in the ubiquitination events central to ribosome-mediated quality control:

  • Effect on eS10/uS10 Ubiquitination: Deletion of EDF1 results in decreased ubiquitination of ribosomal proteins eS10 and uS10 following collision-inducing treatments. Specifically, quantitative proteomics analysis of the doubly diGly-modified eS10-K138/139 peptide shows reduced ubiquitination in ΔEDF1 cells compared to wild-type cells after low-dose emetine treatment .

  • ZNF598 Recruitment: EDF1 contributes to the efficient recruitment of the E3 ubiquitin ligase ZNF598 to polysomes during translational stress. In cells lacking EDF1, a modest decrease (~10-20%) in ZNF598 recruitment is observed following emetine treatment .

  • Hierarchical Positioning: EDF1 functions upstream of ribosomal stall recognition in the quality control pathway, as evidenced by its impact on ZNF598-mediated ubiquitylation events .

This relationship with the ubiquitination machinery demonstrates that EDF1 enhances but is not absolutely required for the initial marking of collided ribosomes, suggesting redundant mechanisms exist to ensure robust quality control responses.

What is the significance of the EDF1-GIGYF2-EIF4E2 axis in translational repression?

The EDF1-GIGYF2-EIF4E2 axis represents a critical negative feedback mechanism that prevents continued translation of problematic mRNAs:

  • Recruitment Hierarchy: Upon ribosomal collision, EDF1 is recruited to the collision interface and subsequently facilitates the recruitment of the translational repressors GIGYF2 and EIF4E2 .

  • Functional Significance: This recruitment establishes a negative feedback loop that prevents new ribosomes from translating defective mRNAs, effectively reducing ribosome density on problematic transcripts .

  • Experimental Evidence: Polysome proteomics experiments in wild-type and ΔEDF1 cells demonstrate that EDF1 is necessary for the emetine-induced recruitment of GIGYF2 to polysomes. Additionally, reporter assays using sequences known to trigger ribosome collisions (such as the unspliced Xbp1 mRNA peptide-pausing sequence) show increased translation output in ΔEDF1 cells compared to controls, confirming EDF1's role in translational repression .

  • Selective Regulation: This system appears to function on multiple types of problematic mRNA sequences, suggesting it represents a general surveillance mechanism rather than a sequence-specific response .

This axis exemplifies how cells utilize hierarchical protein interactions to convert the physical event of ribosome collision into a regulatory response that prevents wasteful translation of defective messages.

How might EDF1 dysfunction contribute to human disease processes?

EDF1 dysfunction could potentially contribute to various disease processes through several mechanisms:

  • Proteostasis Disorders: Given EDF1's role in ribosome-mediated quality control, its dysfunction might lead to accumulation of aberrant proteins, contributing to conditions characterized by proteostatic imbalance such as neurodegenerative disorders.

  • Stress Response Dysregulation: EDF1's function in coordinating transcriptional responses to translational stress suggests its malfunction could impair cellular adaptation to various stressors, potentially contributing to stress-sensitive pathologies.

  • Cancer Progression: As a regulator of both translation and transcription, EDF1 dysfunction might alter cellular growth programs. Its interaction with transcription factors like JUN, which are involved in proliferation and oncogenesis, suggests potential roles in cancer biology .

  • Inflammatory Conditions: The interplay between translational stress responses and inflammatory signaling pathways raises the possibility that EDF1 dysfunction could impact inflammatory processes and related disorders.

Future research should explore these potential disease connections through analysis of EDF1 expression, mutation, and activity in relevant clinical samples and disease models.

What are the most promising methodological approaches for studying temporal dynamics of EDF1-mediated responses?

Understanding the temporal dynamics of EDF1-mediated responses requires sophisticated methodological approaches:

  • Live-Cell Imaging: Implementing CRISPR knock-in of fluorescent tags on endogenous EDF1 and its interaction partners would enable real-time visualization of recruitment kinetics to collided ribosomes.

  • Time-Resolved Proteomics: Applying pulse-SILAC or TMT-based approaches with multiple time points after collision induction would provide quantitative assessment of the temporal sequence of protein recruitment and modification events.

  • Nascent Transcriptome Analysis: Techniques like SLAM-seq (SH-quanTification of uridine-labeled mRNA) or TT-seq (transient transcriptome sequencing) could capture the immediate-early transcriptional response governed by EDF1 following translational stress.

  • Single-Molecule Approaches: Methods like single-molecule fluorescence microscopy could provide insights into the stoichiometry and dynamics of EDF1-ribosome interactions at the individual molecule level.

  • Integrated Multi-omics: Combining ribosome profiling, RNA-seq, and proteomics across a temporal gradient would create a comprehensive view of how EDF1 coordinates the cellular response to ribosomal collisions at multiple regulatory levels.

These approaches would collectively establish the precise temporal relationships between ribosomal collision, EDF1 recruitment, translational repression, and transcriptional activation.

How do post-translational modifications regulate EDF1 function in ribosome-mediated quality control?

Though current research has not fully characterized the post-translational modification (PTM) landscape of EDF1, several hypothetical regulatory mechanisms warrant investigation:

  • Phosphorylation: The proximity of EDF1 to kinases like mTOR, casein kinase II (CKII), and ribosomal protein S6 kinase (RPS6K) in affinity purification studies suggests potential phosphorylation-based regulation . These modifications might modulate EDF1's ability to interact with collision-specific ribosome conformations or downstream effectors.

  • Ubiquitination: Given EDF1's association with the ubiquitin machinery components like ZNF598, it might itself be subject to ubiquitination as part of feedback regulation or to control its abundance at collision sites.

  • PTM-Dependent Localization: Modifications might regulate EDF1's subcellular distribution between cytoplasmic and nuclear compartments, thereby controlling its dual functions in translational and transcriptional regulation.

  • Interaction Surface Regulation: PTMs could alter the binding surfaces that mediate EDF1's interactions with ribosomes, GIGYF2, EIF4E2, and transcription factors, providing a mechanism for context-dependent functional switching.

Systematic proteomic analysis of EDF1 modifications under various cellular stress conditions would help elucidate these regulatory mechanisms and provide insight into how cells fine-tune the ribosome collision response.

Product Science Overview

Gene and Protein Structure

The EDF1 gene is located on chromosome 9q34.3 in humans . The gene undergoes alternative splicing, resulting in multiple transcript variants that encode distinct protein isoforms . The EDF1 protein is also known by several aliases, including Multiprotein Bridging Factor-1 (MBF1) and CFAP280 .

Function and Mechanism

EDF1 functions as a transcriptional coactivator, enhancing the DNA-binding activity of various transcription factors such as ATF1, ATF2, CREB1, and NR5A1 . It achieves this by interconnecting the general transcription factor TATA element-binding protein (TBP) with gene-specific activators . This bridging role is essential for modulating the transcription of genes involved in endothelial differentiation .

Additionally, EDF1 regulates nitric oxide synthase activity, likely by sequestering calmodulin in the cytoplasm . This regulation is vital for maintaining endothelial cell function and vascular health.

Biological Significance

EDF1 is implicated in several critical biological processes:

  • Endothelial Cell Differentiation: EDF1 is essential for the differentiation of endothelial cells, which line the interior surface of blood vessels .
  • Lipid Metabolism: The protein plays a role in lipid metabolism, influencing the body’s ability to process and store fats .
  • Cardiomyocyte Hypertrophy: EDF1 is involved in hormone-induced hypertrophy of cardiomyocytes, the muscle cells of the heart .
Clinical Relevance

Mutations or dysregulation of the EDF1 gene can be associated with various diseases. For instance, EDF1 has been linked to Familial Cold Autoinflammatory Syndrome 2 and Retinitis Pigmentosa 41 . Understanding the function and regulation of EDF1 can provide insights into these conditions and potential therapeutic targets.

Research and Applications

Recombinant EDF1 protein is used in research to study its role in cellular processes and disease mechanisms. By using human recombinant EDF1, scientists can investigate its interactions with other proteins and its impact on gene expression and cellular function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.